Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.

[1]  S Kramer,et al.  A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non‐oat‐cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group , 1980, Cancer.

[2]  F. Muggia,et al.  Lung cancer : progress in therapeutic research , 1979 .

[3]  Z. Petrovich,et al.  Clinical research on the treatment of locally advanced lung cancer. Final report of VALG protocol 13 limited , 1978, Cancer.

[4]  D. Carr.  The staging of lung cancer. , 1974, American Review of Respiratory Disease.

[5]  S. Paloheimo,et al.  Chemotherapy in bronchogenic carcinoma. , 1977, Annals of clinical research.

[6]  L. Rubenstein,et al.  Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. , 1976, Cancer treatment reports.

[7]  J. Cox,et al.  Irradiation for bronchial carcinoma: Reasons for failure. I. Analysis of local control as a function of dose, time, and fractionation , 1976, Cancer.

[8]  M. Feldstein,et al.  Predictors of radiation response in lung cancer. A clinico‐pathobiological analysis , 1976, Cancer.

[9]  H. Barkley,et al.  Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma. , 1975, Cancer chemotherapy reports.

[10]  H. Hansen,et al.  Staging of inoperable patients with bronchogenic carcinoma with special reference to bone marrow examination and peritoneoscopy , 1972, Cancer.

[11]  D. White,et al.  Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamide , 1972, Cancer.

[12]  N. Abramson,et al.  Short-course radiation therapy in carcinoma of the lung. , 1970, Radiology.

[13]  J. Yee,et al.  CELL TYPE AND THE NATURAL HISTORY OF LUNG CANCER. , 1965, JAMA.

[14]  H. Horwitz,et al.  "SUPPRESSIVE" CHEMOTHERAPY IN BRONCHOGENIC CARCINOMA: A RANDOMIZED PROSPECTIVE CLINICAL TRIAL. , 1965, The American journal of roentgenology, radium therapy, and nuclear medicine.

[15]  M. Li,et al.  Bronchogenic carcinoma. A comparative study of the palliative effects of radiation therapy, radiation therapy plus nitrogen mustard, and radiation therapy plus amethopterin and actinomycin D in combination. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.

[16]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .